DMH-1

Overview

DMH-1 is a selective BMP inhibitor. DMH-1 upregulates the expression of SOX1 . DMH-1 increases cardiomyocyte progenitor cells and promotes the differentiation of mouse embryonic stem cells into cardiomyocytes. DMH-1 induces the differentiation of hiPSC-derived neural progenitor cells into β3-tubulin -positive neurons.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Heart Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > TGF-β Receptor | Products > Signaling Pathways > Organoid | Products > Signaling Pathways > Microtubule/Tubulin

Product Information

• Catalog No.: HY-12273
• CAS No.: 1206711-16-1
• Molecular Formula: C24H20N4O
• Molecular Weight: 380.44
• Purity: 99.93%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1 mg/mL (2.63 mM); Clear solution
• Availability: In-stock

Source

Original product source